111 related articles for article (PubMed ID: 9715508)
1. Phenobarbital does not promote hepatic tumorigenesis in a twenty-six-week bioassay in p53 heterozygous mice.
Sagartz JE; Curtiss SW; Bunch RT; Davila JC; Morris DL; Alden CL
Toxicol Pathol; 1998; 26(4):492-500. PubMed ID: 9715508
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and carcinogenicity studies of chlorpromazine hydrochloride and p-cresidine in the p53 heterozygous mouse model.
Petruska JM; Frank DW; Freeman GB; Evans EW; MacDonald JS
Toxicol Pathol; 2002; 30(6):696-704. PubMed ID: 12512871
[TBL] [Abstract][Full Text] [Related]
3. Oxymetholone: III. Evaluation in the p53+/- transgenic mouse model.
Stoll RE; Holden HE; Barthel CH; Blanchard KT
Toxicol Pathol; 1999; 27(5):513-8. PubMed ID: 10528630
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice.
Delker DA; Yano BL; Gollapudi BB
Toxicol Sci; 2000 Jun; 55(2):361-9. PubMed ID: 10828268
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL/10J mouse.
Jones HB; Orton TC; Lake BG
Food Chem Toxicol; 2009 Jun; 47(6):1333-40. PubMed ID: 19298838
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
7. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats.
Kolaja KL; Stevenson DE; Johnson JT; Walborg EF; Klaunig JE
Fundam Appl Toxicol; 1996 Feb; 29(2):219-28. PubMed ID: 8742319
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
9. Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver.
Yamada T; Okuda Y; Kushida M; Sumida K; Takeuchi H; Nagahori H; Fukuda T; Lake BG; Cohen SM; Kawamura S
Toxicol Sci; 2014 Nov; 142(1):137-57. PubMed ID: 25145657
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Lee YS; Nishikawa A
J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
[TBL] [Abstract][Full Text] [Related]
11. Bioassay of mannitol and caprolactam and assessment of response to diethylnitrosamine in heterozygous p53-deficient (+/-) and wild type (+/+) mice.
Iatropoulos MJ; Jeffrey AM; Schlüter G; Enzmann HG; Williams GM
Arch Toxicol; 2001 Mar; 75(1):52-8. PubMed ID: 11357521
[TBL] [Abstract][Full Text] [Related]
12. Assessment of chronic toxicity and carcinogenicity in rats of Wingstay 100, a rubber antioxidant/antiozonant.
Iatropoulos MJ; Williams GM; Wang CX; Brunnemann KD; Leber AP
Exp Toxicol Pathol; 1997 Aug; 49(3-4):153-65. PubMed ID: 9314049
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
Greaves P; Irisarri E; Monro AM
J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179
[TBL] [Abstract][Full Text] [Related]
16. Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor.
Peffer RC; Moggs JG; Pastoor T; Currie RA; Wright J; Milburn G; Waechter F; Rusyn I
Toxicol Sci; 2007 Sep; 99(1):315-25. PubMed ID: 17557908
[TBL] [Abstract][Full Text] [Related]
17. N-Nitroso-N-methylurea initiation in multiple tissues for organ-specific tumor promotion in rats by phenobarbital.
Diwan BA; Palmer AE; Ohshima M; Rice JM
J Natl Cancer Inst; 1985 Dec; 75(6):1099-105. PubMed ID: 3865012
[TBL] [Abstract][Full Text] [Related]
18. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
[TBL] [Abstract][Full Text] [Related]
19. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM
Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of benzophenone (CAS No. 119-61-9). Administered in feed to F344/N rats and B6C3F mice.
Chhabra RS
Toxic Rep Ser; 2000 Apr; (61):1-53, A1-13. PubMed ID: 11803700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
